Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2001-10-30
pubmed:abstractText
Pulmonary arterial hypertension is characterized by increased pulmonary vascular resistance secondary to a decrease in the caliber and number of pulmonary vascular channels. We hypothesized that the targeted overexpression of an angiogenic factor within the lung would potentially minimize the development and progression of pulmonary arterial hypertension by preventing the loss of existing vessels or by inducing the development of new blood vessels within the lung.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
30
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2242-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11684638-Animals, pubmed-meshheading:11684638-Cell Transplantation, pubmed-meshheading:11684638-Cells, Cultured, pubmed-meshheading:11684638-Disease Models, Animal, pubmed-meshheading:11684638-Endothelial Growth Factors, pubmed-meshheading:11684638-Fluorescent Dyes, pubmed-meshheading:11684638-Gene Therapy, pubmed-meshheading:11684638-Gene Transfer Techniques, pubmed-meshheading:11684638-Hypertension, Pulmonary, pubmed-meshheading:11684638-Lung, pubmed-meshheading:11684638-Lymphokines, pubmed-meshheading:11684638-Microcirculation, pubmed-meshheading:11684638-Monocrotaline, pubmed-meshheading:11684638-Muscle, Smooth, Vascular, pubmed-meshheading:11684638-Pulmonary Circulation, pubmed-meshheading:11684638-Rats, pubmed-meshheading:11684638-Rats, Inbred F344, pubmed-meshheading:11684638-Transplantation, Isogeneic, pubmed-meshheading:11684638-Treatment Outcome, pubmed-meshheading:11684638-Vascular Endothelial Growth Factor A, pubmed-meshheading:11684638-Vascular Endothelial Growth Factors
pubmed:year
2001
pubmed:articleTitle
Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.
pubmed:affiliation
Division of Cardiac Surgery, University of Toronto, Terrence Donnelly Heart Centre, St Michael's Hospital, Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't